Cell Therapy Technologies Market by Product (Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes) - Global Forecast to 2025

Publisher: MarketsandMarkets
Publication Date: October, 2020
Healthcare / Medical Devices
Pages: 168
Delivery Format: PDF

by Product (Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes)

Report Features
Table of Contents
Pricing
Methodology
Request Sample
Compare Offers
Make an Offer

The global cell therapy technologies market is projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 14.4% from 2020 to 2025. The growth of this market is driven by the rising government investments in cell-based research, increasing incidence of chronic and infectious diseases, large number of oncology-related cell therapy clinical trials, and increasing GMP certifications for cell therapy production facilities. Also, the emergence of iPSCs as an alternative to ESCs and increased focus on personalized medicine to offer an opportunity for the growth of the market during the forecast period. “Consumables is expected to hold the largest share of the cell therapy technologies market, by product in 2020.” On the basis of product, the market is segmented into consumables, equipment, and systems & software. The consumables segment accounted for the largest share of the cell therapy technologies market in 2019. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market. “T-cells is expected to hold the largest share of the cell therapy technologies market, in 2020.” On the basis of cell type, the market is segmented into, T-cells, stem cells, and other cells. In 2019, T-cells accounted for the largest share of the cell therapy technologies market. Favorable government initiatives and the increasing demand for T-cell therapies are the key factors driving the growth of this segment. “Cell processing is expected to hold the largest share of the cell therapy technologies market in 2020.” On the basis of process, the market is segmented into cell processing, cell preservation, distribution and handling, and process monitoring and quality control. The cell processing segment dominated the market in 2019. This segment is expected to grow at the highest CAGR during the forecast period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment. Biopharmaceutical & biotechnology companies and CROs segment commanded the largest share of the cell therapy technologies market in 2020” By end user, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies and CROs and research institutes and cell banks. Biopharmaceutical & biotechnology companies and CROs dominate the market and are expected to grow at the highest CAGR. The large share of this regional segment can primarily be attributed to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries. “North America commanded the largest share of the cell therapy technologies market in 2020.” On the basis of region, the cell therapy technologies market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America commanded the largest share of the cell therapy technologies market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region. Breakdown of supply-side primary interviews, by company type, designation, and region: • By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%) • By Designation: C-level (30%), Director-level (20%), and Others (50%) • By Region: North America (35%), Europe (24%), AsiaPacific (25%), and RoW (16%). The some of the major players operating in this market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany) and Danaher Corporation (US). List of Companies Profiled in the Report • Thermo Fisher Scientific Inc. (US) • Merck KGaA (Germany) • MaxCyte (US) • Danaher Corporation (US) • Becton, Dickinson and Company (US) • Lonza Group (Switzerland) • Sartorius AG (Germany) • Terumo BCT (US) • Fresenius Medical Care AG & Co. KGaA (Germany) • Avantor, Inc. (US) • Bio-Techne Corporation (US) • Corning Incorporated (US) • FUJIFILM Irvine Scientific (US) • Werum IT Solutions GmbH (Germany) • RoosterBio Inc. (US) • SIRION Biotech GmbH (Germany) • CellGenix GmbH (Germany) • L7 Informatics, Inc. (US) • Miltenyi Biotec GmbH (Germany) • STEMCELL Technologies (Canada) • Hemasoft (US) • MAK-SYSTEM (US) • OrganaBio, LLC (US) • IxCells Biotechnology (China) • Wilson Wolf Corporation (US) Research Coverage This report studies the cell therapy technologies market based on product, cell type, process, end user, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell therapy technologies market. The report forecasts the revenue of the market segments with respect to four major regions. Reasons to Buy the Report: The report provides insights on the following pointers: • Market Penetration: Comprehensive information on cell therapy technologies offered by the top 25 players in the cell therapy technologies market. The report analyzes the cell therapy technologies market by product, cell type, process, end user, and region. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell therapy technologies market • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell therapy technologies market Frequently asked questions • What are the growth opportunities in the cell therapy technologies market across major regions in the future? • Which type of cells are expected to hold the largest share in the cell therapy technologies market? • What are the various cell therapy technologies product types and their respective market shares in the overall market? • Which region has a well-developed cell therapy technologies market? • What is the impact of COVID-19 on cell therapy technologies market?

Offer Amount (Per user license)	Retail price (Per user license)
$ .00	$4,950

Cell Therapy Technologies Market by Product (Consumables, Equipment (Single-Use Equipment, Other Equipment), Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Research Institutes) - Global Forecast to 2025

Are you looking for a Consultant?

Customers Who Viewed This Item Also Viewed